The risk of delirium after sedation with propofol or midazolam in intensive care unit patients
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.16031 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Thomas G van Gelder und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Midazolam, Propofol, Intensive Care Units, Hypnotics and Sedatives. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Society, Chartered Society of Forensic Sciences.
Themen: Intensivpflege, Delir
Abstract (Originalsprache)
Aim
Knowledge of risk factors may provide strategies to reduce the high burden of delirium in intensive care unit (ICU) patients. We aimed to compare the risk of delirium after deep sedation with propofol versus midazolam in ICU patients.
Methods
In this prospective cohort study, ICU patients who were in an unarousable state for ≥24 h due to continuous sedation with propofol and/or midazolam were included. Patients admitted ≤24 h, those with an acute neurological disorder and those receiving palliative sedation were excluded. ICU patients were assessed daily for delirium during the 7 days following an unarousable state due to continuous sedation.
Results
Among 950 included patients, 605 (64%) subjects were delirious during the 7 days after awaking. The proportion of subsequent delirium was higher after midazolam sedation (152/207 [73%] patients) and after both propofol and midazolam sedation (257/377 [68%] patients), compared to propofol sedation only (196/366 [54%] patients). Midazolam sedation (adjusted cause‐specific hazard ratio [adj. cause‐specific HR] 1.32, 95% confidence interval [CI] 1.05‐1.66) and propofol and midazolam sedation (adj. cause‐specific HR 1.29, 95% CI 1.06‐1.56) were associated with a higher risk of subsequent delirium compared to propofol sedation only.
Conclusion
This study among sedated ICU patients suggests that, compared to propofol sedation, midazolam sedation is associated with a higher risk of subsequent delirium. This risk seems more apparent in patients with high cumulative midazolam intravenous doses. Our findings underpin the recommendations of the Society of Critical Care Medicine Pain, Agitation/sedation, Delirium, Immobility (rehabilitation/mobilization), and Sleep (disruption) guidelines to use propofol over benzodiazepines for sedation in ICU patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- Department of Intensive Care Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
- UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
- Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
- Department of Psychiatry, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
ORCID-Profile: Thomas G van Gelder
Förderung
- the Society
- Chartered Society of Forensic Sciences
Zitieren
APA
van Gelder, T. G., van Diem-Zaal, I. J., Dijkstra-Kersten, S. M. A., de Mul, N., Lalmohamed, A., & Slooter, A. J. C. (2024). The risk of delirium after sedation with propofol or midazolam in intensive care unit patients. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16031
Vancouver
van Gelder TG, van Diem-Zaal IJ, Dijkstra-Kersten SMA, de Mul N, Lalmohamed A, Slooter AJC. The risk of delirium after sedation with propofol or midazolam in intensive care unit patients. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16031
BibTeX
@article{vanGelder2024,
author = {van Gelder, Thomas G and van Diem-Zaal, Irene J and Dijkstra-Kersten, Sandra M A and de Mul, Nikki and Lalmohamed, Arief and Slooter, Arjen J C},
title = {The risk of delirium after sedation with propofol or midazolam in intensive care unit patients},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.16031}
}
EUVIMED